Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 387, Issue 11, pp 1025–1036 | Cite as

Treatment with α-lipoic acid enhances the bone healing after femoral fracture model of rats

  • Ali Aydin
  • Zekai Halici
  • Ayhan Akoz
  • Adem Karaman
  • Irmak Ferah
  • Yasin Bayir
  • A. Murat Aksakal
  • Erol Akpinar
  • Jale Selli
  • Halim Kovaci
Original Article

Abstract

This study investigated the fracture-healing effects of α-lipoic acid (α-LA), which was applied orally once daily in preventive treatment mode during 1 month after fracture induction. Rats were randomly divided into sham-operated group (group 1), femoral fracture control (group 2), femoral fracture + 25 mg/kg α-LA (group 3), and femoral fracture + 50 mg/kg α-LA (group 4). Rats in the experimental groups were orally administered 25 or 50 mg/kg α-LA once daily for 30 days starting from postoperative day 1. Thirty days postoperatively, the rats underwent X-ray imaging and were then euthanized for blood and tissue collection. Histopathological, biochemical, molecular, computed tomography (CT), and mechanical strength tests were performed on samples. The serum levels of osteocalcin (OC), osteopontin (OP), tumor necrosis factor alpha (TNF-α), and interleukin-6 (IL-6) did not differ significantly between groups 2 and 3. Serum OC, OP, TNF-α, and IL-6 levels in group 4 were significantly lower than those in group 3. From X-ray images, staging for fracture healing was scored as <2 in group 2, >2 in group 3, and >3 in group 4. In group 2, the average score of less than 2 suggests insufficient fracture healing; those of both the α-LA groups were >2, indicating progression of healing. Transforming growth factor beta (TGF-β) messenger RNA (mRNA) levels were significantly higher in the sham group than in the femoral fracture control. Both doses of α-LA increased TGF-β mRNA expression compared to the fracture group. CT results and biomechanical testing at 4 week after fracture demonstrated that α-LA has fastened bone healing, which was confirmed by stereological analyses in which 50 mg/kg α-LA increased the number of osteoclasts. Our findings indicate that α-LA supplementation promotes healing of femoral fractures in rats.

Keywords

α-Lipoic acid Bone Fracture Cytokines Osteocalcin Osteopontin 

Notes

Acknowledgment

This work was supported by the Ataturk University Medical Research Council (grant number 2011/02).

Conflict of interest

None of the authors have a commercial interest, financial interest, and/or other relationship with manufacturers of pharmaceuticals, laboratory supplies, and/or medical devices or with commercial providers of medically related services.

References

  1. Akman S, Canakci V, Kara A, Tozoglu U, Arabaci T, Dagsuyu IM (2013) Therapeutic effects of alpha lipoic acid and vitamin C on alveolar bone resorption after experimental periodontitis in rats: a biochemical, histochemical, and stereologic study. J Periodontol 84:666–674PubMedCrossRefGoogle Scholar
  2. Bast A, Haenen GR (1988) Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta 963:558–561PubMedCrossRefGoogle Scholar
  3. Beeton CA, Chatfield D, Brooks RA, Rushton N (2004) Circulating levels of interleukin-6 and its soluble receptor in patients with head injury and fracture. J Bone Joint Surg Br 86:912–917PubMedCrossRefGoogle Scholar
  4. Bilska A, Wlodek L (2005) Lipoic acid—the drug of the future? Pharmacol Rep PR 57:570–577Google Scholar
  5. Blokhuis TJ, Buma P, Verdonschot N, Gotthardt M, Hendriks T (2012) BMP-7 stimulates early diaphyseal fracture healing in estrogen deficient rats. J Orthop Res Off Publ Orthop Res Soc 30:720–725CrossRefGoogle Scholar
  6. Bonewald LF, Mundy GR (1990) Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res 261–276Google Scholar
  7. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW (1993) Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22:147–159PubMedCrossRefGoogle Scholar
  8. Boskey AL, Spevak L, Paschalis E, Doty SB, McKee MD (2002) Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 71:145–154PubMedCrossRefGoogle Scholar
  9. Buckwalter JA, Einhorn TA, Marsh JL (2001) Fractures in adults. In: Bucholz RW, Heckman JD (eds.) Bone and joint healing Lippincott, Philadelphia, pp. 245–271Google Scholar
  10. Cadirci E, Altunkaynak BZ, Halici Z, Odabasoglu F, Uyanik MH, Gundogdu C, Suleyman H, Halici M, Albayrak M, Unal B (2010a) Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats. Shock 33:479–484PubMedGoogle Scholar
  11. Cadirci E, Oral A, Odabasoglu F, Kilic C, Coskun K, Halici Z, Suleyman H, Nuri Keles O, Unal B (2010b) Atorvastatin reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Naunyn Schmiedeberg's Arch Pharmacol 381:455–466CrossRefGoogle Scholar
  12. Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA (2003) Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell 14:173–189PubMedCrossRefPubMedCentralGoogle Scholar
  13. Cho TJ, Gerstenfeld LC, Barnes GL, Einhorn TA (2001) Cytokines and fracture healing. Curr Opin Orthop 12:403–408CrossRefGoogle Scholar
  14. Coombes JS, Powers SK, Demirel HA, Jessup J, Vincent HK, Hamilton KL, Naito H, Shanely RA, Sen CK, Packer L, Ji LL (2000) Effect of combined supplementation with vitamin E and alpha-lipoic acid on myocardial performance during in vivo ischaemia-reperfusion. Acta Physiol Scand 169:261–269PubMedCrossRefGoogle Scholar
  15. Cornell CN, Lane JM (1992) Newest factors in fracture healing. Clin Orthop Relat Res 297–311Google Scholar
  16. Demir U, Demir T, Ilhan N (2005) The protective effect of alpha-lipoic acid against oxidative damage in rabbit conjunctiva and cornea exposed to ultraviolet radiation. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd 219:49–53CrossRefGoogle Scholar
  17. Dinarello CA, Mier JW (1987) Lymphokines. N Engl J Med 317:940–945PubMedCrossRefGoogle Scholar
  18. Eastell R, Delmas PD, Hodgson SF, Eriksen EF, Mann KG, Riggs BL (1988) Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 67:741–748PubMedCrossRefGoogle Scholar
  19. Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC (1995) The expression of cytokine activity by fracture callus. J Bone Miner Res Off J Am Soc Bone Miner Res 10:1272–1281CrossRefGoogle Scholar
  20. Estai MA, Suhaimi FH, Das S, Fadzilah FM, Alhabshi SM, Shuid AN, Soelaiman IN (2011) Piper sarmentosum enhances fracture healing in ovariectomized osteoporotic rats: a radiological study. Clinics 66:865–872PubMedCrossRefPubMedCentralGoogle Scholar
  21. Evans JL, Goldfine ID (2000) Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2:401–413PubMedCrossRefGoogle Scholar
  22. Fisher DM, Wong JML, Crowley C, Khan WS (2013) Preclinical and clinical studies on the use of growth factors for bone repair: a systematic review. Curr Stem Cell Res Ther 8:260–268PubMedCrossRefGoogle Scholar
  23. Frost HM (1989) The biology of fracture healing. An overview for clinicians. Part II. Clinical orthopaedics and related research 294–309Google Scholar
  24. Frost A, Jonsson KB, Nilsson O, Ljunggren O (1997) Inflammatory cytokines regulate proliferation of cultured human osteoblasts. Acta Orthop Scand 68:91–96PubMedCrossRefGoogle Scholar
  25. Giannoudis PV, Kontakis G, Christoforakis Z, Akula M, Tosounidis T, Koutras C (2009) Management, complications and clinical results of femoral head fractures. Injury 40:1245–1251PubMedCrossRefGoogle Scholar
  26. Giannoudis PV, Jones E, Einhorn TA (2011) Fracture healing and bone repair. Injury 42:549–550PubMedCrossRefGoogle Scholar
  27. Halici Z, Karaca M, Keles ON, Borekci B, Odabasoglu F, Suleyman H, Cadirci E, Bayir Y, Unal B (2008) Protective effects of amlodipine on ischemia-reperfusion injury of rat ovary: biochemical and histopathologic evaluation. Fertil Steril 90:2408–2415PubMedCrossRefGoogle Scholar
  28. Hashimoto J, Yoshikawa H, Takaoka K, Shimizu N, Masuhara K, Tsuda T, Miyamoto S, Ono K (1989) Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats. Bone 10:453–457PubMedCrossRefGoogle Scholar
  29. Heino TJ, Hentunen TA, Vaananen HK (2002) Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem 85:185–197PubMedCrossRefGoogle Scholar
  30. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317(Pt 1):59–64PubMedPubMedCentralGoogle Scholar
  31. Joffe P, Heaf JG, Hyldstrup L (1994) Osteocalcin: a non-invasive index of metabolic bone disease in patients treated by CAPD. Kidney Int 46:838–846PubMedCrossRefGoogle Scholar
  32. Kalkan Y, Kapakin KA, Kara A, Atabay T, Karadeniz A, Simsek N, Karakus E, Can I, Yildirim S, Ozkanlar S, Sengul E (2012) Protective effect of Panax ginseng against serum biochemical changes and apoptosis in kidney of rats treated with gentamicin sulphate. J Mol Histol 43:603–613PubMedCrossRefGoogle Scholar
  33. Kaplan KA, Odabasoglu F, Halici Z, Halici M, Cadirci E, Atalay F, Aydin O, Cakir A (2012) Alpha-lipoic acid protects against indomethacin-induced gastric oxidative toxicity by modulating antioxidant system. J Food Sci 77:H224–230PubMedCrossRefGoogle Scholar
  34. Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, Delaisse JM, Foged NT (2003) Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J Biol Chem 278:44975–44987PubMedCrossRefGoogle Scholar
  35. Ke HZ, Richards WG, Li X, Ominsky MS (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 33:747–783PubMedCrossRefGoogle Scholar
  36. Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung VT, Brownfield C, Pacifici R (1994) Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 93:1959–1967PubMedCrossRefPubMedCentralGoogle Scholar
  37. Kimble RB, Bain S, Pacifici R (1997) The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res Off J Am Soc Bone Miner Res 12:935–941CrossRefGoogle Scholar
  38. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res Off J Am Soc Bone Miner Res 16:1004–1014CrossRefGoogle Scholar
  39. Korthuis RJ, Granger DN, Townsley MI, Taylor AE (1985) The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 57:599–609PubMedCrossRefGoogle Scholar
  40. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRefGoogle Scholar
  41. Marsell R, Einhorn TA (2011) The biology of fracture healing. Injury 42:551–555PubMedCrossRefPubMedCentralGoogle Scholar
  42. McKibbin B (1978) The biology of fracture healing in long bones. J Bone Joint Surg Br 60-B:150–162PubMedGoogle Scholar
  43. Melhem MF, Craven PA, Liachenko J, DeRubertis FR (2002) Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Ame Soc Nephrol JASN 13:108–116Google Scholar
  44. Nanes MS (2003) Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321:1–15PubMedCrossRefGoogle Scholar
  45. Odabasoglu F, Halici Z, Aygun H, Halici M, Atalay F, Cakir A, Cadirci E, Bayir Y, Suleyman H (2011) α-Lipoic acid has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations. Br J Nutr 105:31–43PubMedCrossRefGoogle Scholar
  46. Orsal E, Halici Z, Bayir Y, Cadirci E, Bilen H, Ferah I, Aydin A, Ozkanlar S, Ayan AK, Seven B, Ozaltin S (2013) The role of carnitine on ovariectomy and inflammation-induced osteoporosis in rats. Exp biol Med 238:1406–1412CrossRefGoogle Scholar
  47. Packer L, Witt EH, Tritschler HJ (1995) alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227–250PubMedCrossRefGoogle Scholar
  48. Pan WT, Einhorn TA (1992) The biochemistry of fracture healing. Curr Orthop 6:207–213CrossRefGoogle Scholar
  49. Papakostidis C, Bhandari M, Giannoudis PV (2013) Distraction osteogenesis in the treatment of long bone defects of the lower limbs: effectiveness, complications and clinical results; a systematic review and meta-analysis. Bone Joint J 95-B:1673–1680PubMedCrossRefGoogle Scholar
  50. Patrick L (2000) Nutrients and HIV: part three—N-acetylcysteine, alpha-lipoic acid, L-glutamine, and L-carnitine. Alternative Med Rev J Clin Ther 5:290–305Google Scholar
  51. Phillips AM (2005) Overview of the fracture healing cascade. Injury 36(Suppl 3):S5–7PubMedCrossRefGoogle Scholar
  52. Polat B, Halici Z, Cadirci E, Albayrak A, Karakus E, Bayir Y, Bilen H, Sahin A, Yuksel TN (2013) The effect of alpha-lipoic acid in ovariectomy and inflammation-mediated osteoporosis on the skeletal status of rat bone. Eur J Pharmacol 718:469–474PubMedCrossRefGoogle Scholar
  53. Price PA, Williamson MK, Lothringer JW (1981) Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 256:12760–12766PubMedGoogle Scholar
  54. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res Off J Am Soc Bone Miner Res 13:1101–1111CrossRefGoogle Scholar
  55. Roelen BA, Dijke P (2003) Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci Off J Japan Orthop Assoc 8:740–748Google Scholar
  56. Sarisozen B, Durak K, Dincer G, Bilgen OF (2002) The effects of vitamins E and C on fracture healing in rats. J Int Med Res 30:309–313PubMedCrossRefGoogle Scholar
  57. Shinar DM, Rodan GA (1990) Biphasic effects of transforming growth factor-beta on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. Endocrinology 126:3153–3158PubMedCrossRefGoogle Scholar
  58. Shuid AN, Mohamad S, Muhammad N, Fadzilah FM, Mokhtar SA, Mohamed N, Soelaiman IN (2011) Effects of alpha-tocopherol on the early phase of osteoporotic fracture healing. J Orthop Res Off Publ Orthop Res Soc 29:1732–1738CrossRefGoogle Scholar
  59. Skjodt H, Russell G (1992) Bone cell biology and the regulation of bone metabolism. In: Gown M (ed) Cytokines and Bone Metabolism. CRC Press, Boca Raton, pp 1–70Google Scholar
  60. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM (1987) Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138:1464–1468PubMedGoogle Scholar
  61. Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (2002) Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res Off J Am Soc Bone Miner Res 17:1486–1497CrossRefGoogle Scholar
  62. Thiede MA, Smock SL, Petersen DN, Grasser WA, Thompson DD, Nishimoto SK (1994) Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 135:929–937PubMedGoogle Scholar
  63. van Acker SA, Koymans LM, Bast A (1993) Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Radic Biol Med 15:311–328PubMedCrossRefGoogle Scholar
  64. Wang X, Yu Y, Ji L, Liang X, Zhang T, Hai CX (2011) Alpha-lipoic acid protects against myocardial ischemia/reperfusion injury via multiple target effects. Food Chem Toxicol Int J published Br Ind Biol Res Assoc 49:2750–2757CrossRefGoogle Scholar
  65. Xu H, Watkins BA, Seifert MF (1995) Vitamin E stimulates trabecular bone formation and alters epiphyseal cartilage morphometry. Calcif Tissue Int 57:293–300PubMedCrossRefGoogle Scholar
  66. Ziegler D, Reljanovic M, Mehnert H, Gries FA (1999) Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes Off J Ger Soc of Endocrinol Ger Diabetes Association 107:421–430CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Ali Aydin
    • 1
  • Zekai Halici
    • 2
  • Ayhan Akoz
    • 3
  • Adem Karaman
    • 4
  • Irmak Ferah
    • 2
  • Yasin Bayir
    • 5
  • A. Murat Aksakal
    • 6
  • Erol Akpinar
    • 2
  • Jale Selli
    • 7
  • Halim Kovaci
    • 8
  1. 1.Department of Orthopedics and Traumatology, Faculty of MedicineAtaturk UniversityErzurumTurkey
  2. 2.Department of Pharmacology, Faculty of MedicineAtaturk UniversityErzurum,Turkey
  3. 3.Department of Emergency Medicine, Faculty of MedicineAtaturk UniversityErzurumTurkey
  4. 4.Department of Radiology, Faculty of MedicineAtaturk UniversityErzurumTurkey
  5. 5.Department of Biochemistry, Faculty of PharmacyAtaturk UniversityErzurumTurkey
  6. 6.Department of Orthopedics and TraumatologySevket Yilmaz Education and Research HospitalBursaTurkey
  7. 7.Department of Histology and Embriology, Faculty of MedicineAtaturk UniversityErzurumTurkey
  8. 8.Department of Mechanical Engineering, Faculty of EngineeringAtaturk UniversityErzurumTurkey

Personalised recommendations